SalioGen Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States51-200 Employees

SalioGen Therapeutics is a biotechnology company based in Lexington, Massachusetts, focused on developing next-generation genetic medicines. Its lead programs aim at one-time treatments for retinal and pulmonary diseases, including Stargardt disease and cystic fibrosis, with a broader plan to apply its Gene Coding technology to other inherited conditions and to engineer CAR-T cells for cancer and autoimmune diseases. The company positions itself in the biotechnology research sector by pursuing non-viral genome integration that aims to avoid double-strand breaks and the use of guide RNA, addressing safety and efficacy considerations associated with other genetic medicine approaches. SalioGen emphasizes durable genetic edits delivered at precise genomic locations, seeking to advance treatments that could provide long-term or lifelong benefits for patients. The organization operates from Lexington, in the United States, and has publicly shared recent updates highlighting ongoing development and collaboration activity in its genetic medicine programs.

Sign up for free to view info

Company overview Email format